An investigation for investors in NYSE:BMY shares was announced over potential breaches of fiduciary duties by certain officers and directors at Bristol-Myers Squibb.
Investors who purchased shares of Bristol-Myers Squibb Co (NYSE:BMY) and currently hold any of those NYSE:BMY shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Bristol-Myers Squibb Co officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
In October 2015, Bristol-Myers Squibb Co reached a civil settlement with the Securities and exchange Commission (“SEC”) of alleged Foreign Corrupt Practices Act (FCPA) violations in which the Company agreed to approximately $14.7 million in disgorgement, penalties and interest.
On August 23, 2016, NYSE:BMY shares closed at $58.76 per share.
Those who purchased NYSE:BMY shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego